Analytical Data
-
Gene name
CYTL1
- Application
-
Alternative Names
CYTL1；C4orf4；Cytokine-like Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NRR1
-
Expression Region
1-136aa
-
AA Sequence
MRTPGPLPVL LLLLAGAPAA RPTPPTCYSR MRALSQEITR DFNLLQVSEP SEPCVRYLPR LYLDIHNYCV LDKLRDFVAS PPCWKVAQVD SLKDKARKLY TIMNSFCRRD LVFLLDDCNA LEYPIPVTTV LPDRQR
-
Molecular Weight
40 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CYTL1, or Cytokine-like 1, is a secreted protein belonging to the IL-6 cytokine family and has garnered interest due to its potential role in immune responses and inflammatory processes. Initially identified in 2001, research has uncovered its involvement in various physiological and pathological conditions, including cancer, where it may influence tumor growth and metastasis. CYTL1 expression has been linked to immune regulation, particularly in the context of promoting Th2-type immune responses, which have implications for allergic diseases and asthma. The protein is also thought to play a role in hematopoiesis and may impact angiogenesis and tissue repair mechanisms. Given its diverse biological functions, the expressed recombinant CYTL1 protein has become a key focus for studying its structure-function relationships and therapeutic potential. Ongoing research aims to elucidate the precise molecular mechanisms underlying its actions, paving the way for novel therapeutic strategies targeting CYTL1 in various diseases, including cancer and autoimmune disorders. The development of recombinant CYTL1 serves not only as a valuable tool for further investigations but also holds promise for potential clinical applications in modulating immune responses.
